Karin H.
- Country
- Denmark
- Department
- Onkologisk afdeling R
Research Overview
Data & Insights
Has run more than one trial at 0 of 3 partner sites.
Specializations
Lung Cancer Research
The investigator specializes in developing innovative treatments for non-small cell lung cancer (NSCLC), with particular emphasis on combination therapeutic approaches. Their research explores targeted interventions in advanced stages of the disease.
- NSCLC Treatment Optimization
- Combination Therapy Assessment
- Anti-TIGIT Therapy Development
Primary focus includes evaluating novel drug combinations incorporating immunotherapy agents for enhanced treatment outcomes.
Advanced Solid Tumors
The investigator conducts research in treating advanced and metastatic solid tumors, exploring both monotherapy and combination treatment approaches. Their work encompasses evaluation of novel therapeutic agents.
- Novel Drug Development
- Immunotherapy Combinations
- Treatment Safety Profiles
Expertise extends to determining optimal dosing strategies and evaluating treatment tolerability in advanced cancer cases.
Immunotherapy Innovation
The investigator focuses on advancing immunotherapeutic approaches in cancer treatment, particularly examining the effectiveness of pembrolizumab-based combinations across different cancer types.
- Immune Checkpoint Inhibition
- Therapeutic Co-formulations
- Treatment Response Assessment
Their work includes evaluating novel immunotherapy combinations for improved patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.